Literature DB >> 27640995

Association between Giardia and arthritis or joint pain in a large health insurance cohort: could it be reactive arthritis?

J E Painter1, S A Collier2, J W Gargano2.   

Abstract

This study aimed to assess the association between giardiasis and subsequent development of arthritis or joint pain using a retrospective cohort of individuals from a large administrative claims database in the United States. Using 2006-2010 data from MarketScan Commercial Claims and Encounters, we conducted a retrospective cohort study in people with an ICD-9-CM code for giardiasis (n = 3301) and persons without giardiasis (n = 14 612) individually matched on age, sex, and enrolment length. We used conditional logistic regression to model the association between giardiasis and arthritis or joint pain documented in the 6 months following initial giardiasis diagnosis or index date for matched controls. After adjusting for healthcare utilization rate, giardiasis was associated with a 51% increase in claims for arthritis or joint pain (odds ratio 1·51, 95% confidence interval 1·26-1·80). In age- and sex-stratified adjusted analyses, the association remained significant across all subgroups (age 0-19 years, age 20-64 years, males, and females). Findings from this study lend epidemiological support for the association between giardiasis and subsequent development of arthritis. Reactive arthritis might occur more frequently than has been reported in the literature. Further research is necessary to determine the mechanisms by which giardiasis could lead to arthritis.

Entities:  

Keywords:  zzm321990 Giardiazzm321990 ; Arthritis; commercial claims data; giardiasis; medical claims; post-infectious arthritis; reactive arthritis

Mesh:

Year:  2016        PMID: 27640995      PMCID: PMC9507630          DOI: 10.1017/S0950268816002120

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  34 in total

1.  Prevalence of enteric pathogens among community based asymptomatic individuals.

Authors:  M E Hellard; M I Sinclair; G G Hogg; C K Fairley
Journal:  J Gastroenterol Hepatol       Date:  2000-03       Impact factor: 4.029

2.  HLA-B27 expression and reactive arthritis susceptibility in two patient cohorts infected with Salmonella Typhimurium.

Authors:  G J McColl; M B Diviney; R F Holdsworth; P D McNair; J Carnie; W Hart; J McCluskey
Journal:  Aust N Z J Med       Date:  2000-02

3.  Giardiasis-associated arthralgia in children.

Authors:  F Meza-Ortíz
Journal:  Arch Med Res       Date:  2001 May-Jun       Impact factor: 2.235

Review 4.  Reactive arthritis.

Authors:  Timo Hannu
Journal:  Best Pract Res Clin Rheumatol       Date:  2011-06       Impact factor: 4.098

5.  Seasonal prevalences of Cryptosporidium and Giardia infections in children attending day care centres in Salamanca (Spain) studied for a period of 15 months.

Authors:  J Rodríguez-Hernández; A Canut-Blasco; A M Martín-Sánchez
Journal:  Eur J Epidemiol       Date:  1996-06       Impact factor: 8.082

6.  Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke.

Authors:  Henrik Källberg; Bo Ding; Leonid Padyukov; Camilla Bengtsson; Johan Rönnelid; Lars Klareskog; Lars Alfredsson
Journal:  Ann Rheum Dis       Date:  2010-12-13       Impact factor: 19.103

7.  Reactive arthritis following an outbreak of Salmonella typhimurium phage type 193 infection.

Authors:  T Hannu; L Mattila; A Siitonen; M Leirisalo-Repo
Journal:  Ann Rheum Dis       Date:  2002-03       Impact factor: 19.103

8.  Reactive arthritis following culture-confirmed infections with bacterial enteric pathogens in Minnesota and Oregon: a population-based study.

Authors:  J M Townes; A A Deodhar; E S Laine; K Smith; H E Krug; A Barkhuizen; M E Thompson; P R Cieslak; J Sobel
Journal:  Ann Rheum Dis       Date:  2008-02-13       Impact factor: 19.103

9.  Increased frequency and costs of ambulatory medical care utilization prior to the diagnosis of rheumatoid arthritis: a national population-based study.

Authors:  Ning-Sheng Lai; Tzung-Yi Tsai; Chung-Yi Li; Malcolm Koo; Chia-Li Yu; Ming-Chi Lu
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-03       Impact factor: 4.794

10.  Post-Salmonella reactive arthritis: late clinical sequelae in a point source cohort.

Authors:  G T Thomson; D A DeRubeis; M A Hodge; C Rajanayagam; R D Inman
Journal:  Am J Med       Date:  1995-01       Impact factor: 4.965

View more
  4 in total

1.  Risk factors for sporadic Giardia infection in the USA: a case-control study in Colorado and Minnesota.

Authors:  H E Reses; J W Gargano; J L Liang; A Cronquist; K Smith; S A Collier; S L Roy; J Vanden Eng; A Bogard; B Lee; M C Hlavsa; E S Rosenberg; K E Fullerton; M J Beach; J S Yoder
Journal:  Epidemiol Infect       Date:  2018-05-09       Impact factor: 4.434

2.  Decreased fecal calprotectin levels in Spondyloarthritis patients colonized by Blastocystis spp.

Authors:  Jacqueline Chaparro-Olaya; Liliana Morales; Moisés David León Falla; Paula C Hernández; Wilson Bautista-Molano; Alejandro Ramos-Casallas; Juliette de Ávila; Juan Manuel Bello-Gualtero; Fabián Cortés Muñoz; Consuelo Romero-Sánchez
Journal:  Sci Rep       Date:  2022-09-23       Impact factor: 4.996

Review 3.  Chronic Gastrointestinal and Joint-Related Sequelae Associated with Common Foodborne Illnesses: A Scoping Review.

Authors:  Kristen Pogreba-Brown; Erika Austhof; Alexandra Armstrong; Kenzie Schaefer; Lorenzo Villa Zapata; D Jean McClelland; Michael B Batz; Maria Kuecken; Mark Riddle; Chad K Porter; Michael C Bazaco
Journal:  Foodborne Pathog Dis       Date:  2019-10-07       Impact factor: 3.788

4.  Determining the long-term health burden and risk of sequelae for 14 foodborne infections in British Columbia, Canada: protocol for a retrospective population-based cohort study.

Authors:  Shannon E Majowicz; Dimitra Panagiotoglou; Marsha Taylor; Mahmood R Gohari; Gilaad G Kaplan; Ashok Chaurasia; Scott T Leatherdale; Richard J Cook; David M Patrick; Steen Ethelberg; Eleni Galanis
Journal:  BMJ Open       Date:  2020-08-31       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.